Editor-in-Chief Dr Catherine Otto talks to Dr Elizabeth Mostofsky at the Cardiac Society of Australia & New Zealand meeting in Melbourne. They discuss the various environmental, physical and psychological triggers for heart disease.

Editor-in-Chief Dr Catherine Otto talks to Dr Carolyn Lam at the Cardiac Society of Australia & New Zealand meeting in Melbourne. They discuss her session on heart failure with preserved ejection fraction.

Editor-in-Chief Dr Catherine Otto talks to Dr David Calemajer at the Cardiac Society of Australia & New Zealand meeting in Melbourne. They discuss his session on managing the large spectrum of Ebstein's anomaly in adults in the absence of RCT data.

Chocolate is an important dietary source of flavonoid antioxidants, which are hypothesised to have a beneficial effect on endothelial function and protect against cardiovascular disease (CVD).

In this podcast Dr Alistair Lindsay talks to Dr Phyo K Myint about his team's research into this topic. In order to evaluate any association between habitual chocolate consumption and the risk of cardiovascular events, they analysed data from the European Prospective Investigation into Cancer-Norfolk (EPIC-Norfolk), and incorporated the results from this observational study into the evidence available to date.

Aortic valve stenosis (AS) is a progressive disease, but the impact of baseline AS haemodynamic or anatomic severity on AS progression remains unclear. In this podcast Dr Alistair Lindsay talks to Dr Virginia Nguyen about her study to evaluate the impact of baseline AS severity assessed, either by using echocardiography (haemodynamic assessment) or MSCT (anatomic assessment) on AS progression.

Percutaneous Coronary Intervention (PCI) has a considerable evidence base and it is firmly established as the most common procedure used in the invasive treatment of patients with CHD in the UK. The evidence base relating to PCI has been reviewed and this has been published in Heart. The guidelines focus on issues pertinent to practice within the UK and set out a recommended template to ensure optimal delivery of patient care. Dr Alistair Lindsay speaks to Professor Adrian Banning from the John Radcliffe Hospital at the University of Oxford who was co-author on the guidelines.

Dr Alistair Lindsay speaks to Dr Tomasz Baron about his research which aimed to assess differences in incidence, clinical features, current treatment strategies and outcome in patients with type 2 vs. type 1 acute myocardial infarction (AMI).

Full paper found here >> http://heart.bmj.com/content/101/2/101.full?sid=e9538ca9-604b-40af-95a7-c03f016f4c2e

Frailty in older age is known to be associated with cardiovascular disease (CVD) risk. However, the extent to which frailty is associated with the CVD risk profile has been little studied. Dr Alistair Lindsay talked to Dr Sheena Ramsay about her study and the clinical implications of the results.

The original paper can be found here: http://heart.bmj.com/content/101/8/616.full?sid=767613b9-71bb-41af-80e8-361647c03828

Dr Alistair Lindsay spoke to Dr Eliseo Guallar about his study to nvestigate the association between regular coffee consumption and the prevalence of coronary artery calcium (CAC) in a large sample of young and middle-aged asymptomatic men and women.

Read the article here http://heart.bmj.com/content/early/2015/02/06/heartjnl-2014-306663.full?sid=3959ea9e-52ba-4e69-97fa-1b55aa2b9738

Dr Alistair Lindsay speaks to Dr Edward Carlton about his published paper investigating whether a novel accelerated diagnostic protocol (ADP) for suspected acute coronary syndrome (ACS) could successfully identify low-risk patients suitable for discharge after a single high-sensitivity troponin T.